Ole Andreas Halvorsen
Viking Global Investors
Viking Global Investors 13F holdings
Ole Andreas Halvorsen's Portfolio
- Portfolio value:
- $23.54B~
- # of securities:
- 55 (-8)
- Reported for:
- 30 Jun 2016 (Q2)
- Latest filing date:
- 15 Aug 2016
What stocks did Ole Andreas Halvorsen own in 2016 Q2?
What was Ole Andreas Halvorsen's 2016 Q2 portfolio?
Viking Global Investors has disclosed a total of 55 security holdings in their (2016 Q2) SEC 13F filing(s) with portfolio value of $23,540,602,000.
Viking Global Investors's portfolio holdings are tracked quarterly based on SEC 13F filings. Snapshots for each reporting period document the full list of disclosed positions and their portfolio allocations.
Ole Andreas Halvorsen's original 13F reports (2016 Q2) are the official SEC institutional disclosure documents covering all reported equity positions.
55 results
| History | Ticker | Name |
% of portfolio |
Shares* |
Reported price* |
% difference current price* |
Value | Held since* | Held for* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Amazon.com Inc
|
9.97%
|
$35.78
|
+632.32%($262.03)
|
2015 Q2
|
~1.25 years
|
-4.61% (-3.17M)
|
||||
|
|
Meta Platforms Inc
|
9.78%
|
$114.28
|
+388.08%($557.78)
|
2016 Q1
|
~0.50 years
|
+0.06% (+11.71K)
|
||||
|
|
Broadcom Inc
|
6.75%
|
$15.54
|
+2,222.54%($360.92)
|
2015 Q2
|
~1.25 years
|
+3.94% (+3.87M)
|
||||
|
|
Teva Pharma Industries Ltd ADR
|
5.92%
|
$50.23
|
-26.25%($37.04)
|
2015 Q3
|
~1.00 year
|
-15.88% (-5.23M)
|
||||
|
|
Alphabet Inc, CL-A
|
5.36%
|
$35.18
|
+892.03%($348.96)
|
2014 Q3
|
~2.00 years
|
-12.46% (-5.11M)
|
||||
|
|
Air Products and Chemicals Inc
|
4.19%
|
$142.04
|
+113.41%($303.12)
|
2014 Q3
|
~2.00 years
|
+0.52% (+36.23K)
|
||||
|
|
Coterra Energy Inc
|
3.86%
|
$25.74
|
|
2015 Q4
|
~0.75 years
|
-2.96% (-1.08M)
|
||||
|
|
Biogen Inc
|
3.30%
|
$241.82
|
-10.59%($216.21)
|
2015 Q4
|
~0.75 years
|
+1,290.15% (+2.98M)
|
||||
|
|
Eli Lilly and Company
|
3.14%
|
$78.75
|
+1,481.41%($1,245.36)
|
2016 Q1
|
~0.50 years
|
-20.29% (-2.39M)
|
||||
|
|
ENCANA CORP
|
2.67%
|
$7.79
|
|
2015 Q4
|
~0.75 years
|
|
||||
Completely sold out
21 results
| History | Ticker | Name |
Sold shares* |
% change to portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|
|
|
Elevance Health Inc
|
2015 Q2
|
~1.00 year
|
|||
|
|
Transdigm Group Incorporated
|
2015 Q2
|
~1.00 year
|
|||
|
|
Prudential Financial, Inc
|
2015 Q4
|
~0.50 years
|
|||
|
|
ENDO HEALTH SOLUTIONS INC COM
|
2015 Q4
|
~0.50 years
|
|||
|
|
Chubb Ltd
|
2016 Q1
|
~0.25 years
|
|||
|
|
MetLife Inc
|
2016 Q1
|
~0.25 years
|
|||
|
|
JARDEN CORP
|
2016 Q1
|
~0.25 years
|
|||
|
|
Laboratory Corp of America Holdings
|
2015 Q3
|
~0.75 years
|
|||
|
|
The Home Depot Inc
|
2016 Q1
|
~0.25 years
|
|||
|
|
Progressive Corp
|
2016 Q1
|
~0.25 years
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted. 2013 Q2 is the earliest period we have data for, so "2013 Q2*" means "2013 Q2 or earlier".
* % of portfolio: the total can exceed 100%, e.g. when there are also options positions, which can be short.